Cervical cancer shots less cost-effective with age, U.S. study shows

ATLANTA - An expensive vaccine aimed at preventing cervical cancer makes sense for young teens when it comes to cost-effectiveness, but not for women in their 20s, contends a new report. The vaccine against the HPV virus was licensed the U.S....More